we won the top 100 public voting in the biotech category

We are beyond excited to share that Recolony has won the Top 100 Swiss Startups Public Voting 2024 in the Biotech category!

This award is especially meaningful to us because it was decided by public vote, a clear signal of trust and enthusiasm from our community, supporters, and everyone who believes in our mission to revolutionize cancer therapy through precision immunotherapy.